News & Analysis on Clinical Trial Services & Contract Research And Development
Delays are annoying. Whether you are a journalist trying to ask a few quick questions without involving teams of public relations people or a driver stuck in a traffic jam, delays are normally a bad thing.
PRA CEO Colin Shannon tells Outsourcing-pharma.com merger with RPS will provide geographic and client base growth. Analysts say it is a positive move for two mid-sized CROs.
IMCD has bought Sydney-based drug and food ingredient distributor Capitol Ingredients Australia to increase its access to local markets.
Building on similar European documents, Australia’s TGA (Therapeutic Goods Administration) released guidance Tuesday to help assist drugmakers looking to win approval for their biosimilars.
Covance reported 10% revenue growth between the second quarter of this year and the same quarter last year, mostly due to central laboratories and late-stage development growth.
Ireland-based commercialization services firm United Drug has announced plans to buy Spanish contract pharmaceutical sales group Expansis for €12m ($15m).
Hospira linked its improved Q2 results to progress made in efforts to address quality problems at various manufacturing plants, but the 483s and Warning Letters are still coming.